VCYT
Veracyte Inc
NASDAQ: VCYT · HEALTHCARE · DIAGNOSTICS & RESEARCH
$50.31
+0.06% today
Updated 2026-10-28
Market cap
$4.04B
P/E ratio
35.94
P/S ratio
7.20x
EPS (TTM)
$1.40
Dividend yield
—
52W range
$29 – $61
Volume
1.3M
Veracyte Inc (VCYT) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$50.31
12-Month target
$25.71
2030 Target
—
Intrinsic (DCF)
$86.20
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.2B | $0.3B | $0.4B | $0.4B | $0.5B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 20.40%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.